dc.contributor.author
Gomez-Peralta, Fernando
dc.contributor.author
Abreu, Cristina
dc.contributor.author
Lecube Torelló, Albert
dc.contributor.author
Bellido, Diego
dc.contributor.author
Soto, Alfonso
dc.contributor.author
Morales, Cristóbal
dc.contributor.author
Brito-Sanfiel, Miguel
dc.contributor.author
Umpierrez, Guillermo
dc.date.accessioned
2024-12-05T21:41:29Z
dc.date.available
2024-12-05T21:41:29Z
dc.date.issued
2017-11-20T11:16:18Z
dc.date.issued
2017-11-20T11:16:18Z
dc.identifier
https://doi.org/10.1007/s13300-017-0290-3
dc.identifier
http://hdl.handle.net/10459.1/60513
dc.identifier.uri
http://hdl.handle.net/10459.1/60513
dc.description.abstract
Erratum to: practical approach to initiating SGLT2 inhibitors in type 2 diabetes.
dc.publisher
Springer Verlag
dc.relation
Reproducció del document publicat a https://doi.org/10.1007/s13300-017-0290-3
dc.relation
Diabetes Therapy, 2017, vol. 8, núm. 5, p. 963-965
dc.rights
cc-by-nc (c) Gomez-Peralta et al., 2017
dc.rights
info:eu-repo/semantics/openAccess
dc.rights
http://creativecommons.org/licenses/by-nc/4.0/
dc.title
Erratum to: practical approach to initiating SGLT2 inhibitors in type 2 diabetes
